M Robain|F Boufassa|J B Hubert|A Persoz|M Burgard|L Meyer|

Showing results (1-10 of 1,743) with videos related to

Pageof 175

Sort By:

AIDS (London, England)|February 24, 2001

Cytomegalovirus seroconversion as a cofactor for progression to AIDSM Robain, F Boufassa, J B Hubert, et al.

AIDS (London, England)|April 19, 2000

Sexual behavior changes and protease inhibitor therapy. SEROCO Study GroupM Miller, L Meyer, F Boufassa, et al.

Epidemiology and Infection|December 16, 2000

Is cytomegalovirus infection a co-factor in HIV-1 disease progression?M Robain, F Boufassa, J B Hubert, et al.

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|June 1, 1996

The use of auxiliary events to improve the analysis of survival for HIV-infected patients: application to the French Prospective Multicenter Cohort (SEROCO)P Flandre, F Boufassa, L Gerard, et al.

AIDS (London, England)|January 1, 1996

High risk of HIV disease progression after infection through a sexual partner with AIDSN Carré, L Meyer, F Boufassa, et al.

Revue D'Epidemiologie Et De Sante Publique|April 10, 2003

[Management of the bank of biological material in the hospital-based SEROCO and HEMOCO cohorts of HIV-infected patients]L Meyer, M Gharib, J Lerable, et al.

International Journal of Epidemiology|December 5, 1998

Predictive value of viral load and other markers for progression to clinical AIDS after CD4+ cell count falls below 200/microL. SEROCO & HEMOCO Study GroupN Carré, F Boufassa, J B Hubert, et al.

The Journal of Infectious Diseases|May 1, 1995

Influence of neurologic manifestations of primary human immunodeficiency virus infection on disease progression. SEROCO Study GroupF Boufassa, C Bachmeyer, N Carré, et al.

Journal De Gynecologie, Obstetrique Et Biologie De La Reproduction|September 2, 2005

[Pregnancy termination between 12 and 14 weeks gestation: practices and early complications in comparison with termination between 8 and 12 weeks]F Bacle, F Boufassa, J Lambert, et al.

AIDS (London, England)|June 1, 1994

Effect of age and exposure group on the onset of AIDS in heterosexual and homosexual HIV-infected patients. SEROCO Study GroupN Carré, C Deveau, F Belanger, et al.

Pageof 175

Showing results (1-10 of 1,743) with videos related to

Sort By:

Pageof 175

AIDS (London, England)|February 24, 2001

Cytomegalovirus seroconversion as a cofactor for progression to AIDSM Robain, F Boufassa, J B Hubert, et al.

AIDS (London, England)|April 19, 2000

Sexual behavior changes and protease inhibitor therapy. SEROCO Study GroupM Miller, L Meyer, F Boufassa, et al.

Epidemiology and Infection|December 16, 2000

Is cytomegalovirus infection a co-factor in HIV-1 disease progression?M Robain, F Boufassa, J B Hubert, et al.

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|June 1, 1996

The use of auxiliary events to improve the analysis of survival for HIV-infected patients: application to the French Prospective Multicenter Cohort (SEROCO)P Flandre, F Boufassa, L Gerard, et al.

AIDS (London, England)|January 1, 1996

High risk of HIV disease progression after infection through a sexual partner with AIDSN Carré, L Meyer, F Boufassa, et al.

Revue D'Epidemiologie Et De Sante Publique|April 10, 2003

[Management of the bank of biological material in the hospital-based SEROCO and HEMOCO cohorts of HIV-infected patients]L Meyer, M Gharib, J Lerable, et al.

International Journal of Epidemiology|December 5, 1998

Predictive value of viral load and other markers for progression to clinical AIDS after CD4+ cell count falls below 200/microL. SEROCO & HEMOCO Study GroupN Carré, F Boufassa, J B Hubert, et al.

The Journal of Infectious Diseases|May 1, 1995

Influence of neurologic manifestations of primary human immunodeficiency virus infection on disease progression. SEROCO Study GroupF Boufassa, C Bachmeyer, N Carré, et al.

Journal De Gynecologie, Obstetrique Et Biologie De La Reproduction|September 2, 2005

[Pregnancy termination between 12 and 14 weeks gestation: practices and early complications in comparison with termination between 8 and 12 weeks]F Bacle, F Boufassa, J Lambert, et al.

AIDS (London, England)|June 1, 1994

Effect of age and exposure group on the onset of AIDS in heterosexual and homosexual HIV-infected patients. SEROCO Study GroupN Carré, C Deveau, F Belanger, et al.

Pageof 175